Hanyang Med Rev.  2009 Aug;29(3):204-209. 10.7599/hmr.2009.29.3.204.

Advanced Laryngeal Cancer: Surgical and Non-surgical Management Options

• Kim KH

• KMID: 1505096
• DOI: http://doi.org/10.7599/hmr.2009.29.3.204

Abstract

Until the early 1990s, the standard treatment for locally advanced laryngeal cancer was total laryngectomy. During the past 20 years, effort was made to save the larynx by using chemotherapy combined with radiation and there has been significant progression in survival and the preservation of the function of larynx in recent days. Now, the standard treatment option for advanced laryngeal cancer is changing from radical surgery to induction or concurrent chemoradiation and the surgery is mainly reserved for salvage operation. But, the quality of life after CCRT is sometimes unacceptable due to severe side effects and some prefer function preserving surgery. The decision for surgical or nonsurgical options needs to be made according to patient's wishes and quality of life goals from a multidisciplinary approach with medical oncologists, radiation oncologists, and head and neck surgeons. Chemoradiation therapy allows for nonsurgical management, but judicious use is recommended because the surgical salvage for failure is much more complicated.

Keyword

Laryngeal cancer; Organ preservation; Laryngectomy; Chemotherapy; Radiation

MeSH Terms

Drug Therapy
Head
Laryngeal Neoplasms*
Laryngectomy
Larynx
Neck
Organ Preservation
Quality of Life

Reference

1. The American Joint Committee on Cancer. Larynx. AJCC cancer staging manual. 6th ed. New York, USA: Springer;2002. p. 47–57.

2. Robin PE, Rockley T, Powel DJ, Reid A. Survival of cancer of the larynx related to treatment. Clin Otolaryngol Allied Sci. 1991; 16:193–197.

3. Ogura JH. Surgical pathology of carcinoma of larynx. Laryngoscope. 1955; 5:867–926.

4. Weinstein GS. Surgical approach to organ preservation in treatment of cancer of the larynx. Oncology (Williston Park). 2001; 15:785–796.

5. Davis RK, Kriskovich MD, Galloway EB III, Buntin CS, Jepsen MC. Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol. 2004; 113:132–138.

6. Sewell DA. Supracricoid partial laryngectomy with cricohyoidopexy. Oper tech otolaryngol-head neck surg. 2003; 14:27–33.

7. Rasekh CH, Johnson JT. Controversies in management of the N0 neck in squamous cell carcinoma of the upper aerodigestive tract. In : Bailey BJ, Calhoun KH, Healy GB, editors. Head and neck surgery-otolaryngology. 3rd ed. Philadelphia, USA: Lippincott Williams and Wilkins;2001. p. 1367–1375.

8. American Head and Neck Society. Larynx-supraglottic. American Head and Neck Society Clinical Practice Guidelines. Los Angeles, USA: 1995.

9. Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A. Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol. 2002; 122:438–442.

10. The department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324:1685–1690.

11. DeSanto LW. Cancer of the larynx. Curr Opin Otolaryngol Head Neck Surg. 1993; 1:133–136.

12. Moyer JS, Wolf GT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:82–87.

13. Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK. Department of Veterans Affairs Laryngeal Cancer Study Group. Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Ann Otol Rhinol Laryngol Suppl. 1998; 172:1–27.

14. Terrell JE, Fisher SG, Wolf GT. Long term quality of life after treatment for laryngeal cancer. Arch Otolaryngol Head Neck Surg. 1998; 124:964–971.

15. Forastiere AA, Berkey B, Maor M. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone. Intergroup Trial R91-11. Proc Am Soc Clin Oncol. 2001; 20:2a.

16. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349:2091–2098.

17. Kraus DH, Pfister DG, Harrison LB, Sprio RH, Strong EW, Zelefsky M, Bosl GJ, Shah JP. Salvage laryngectomy for unsuccessful larynx preservation therapy. Ann Otol Rhinol Laryngol. 1995; 104:936–941.

18. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy. Analysis of wound complications. Arch Otolaryngol Head Neck Surg. 1995; 121:162–165.

19. Cmelak AJ, Li S, Goldwasser MA, Murhy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere A. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinoma of the larynx or oropharynx: results of eastern cooperative oncology group study E2399. J Clin Oncol. 2007; 25:3971–3977.

20. Holsinger FC, Kies MS, Diaz EM, Gillenwater AM, Lewin JS, Ginsberg LE, Glisson BS, Garden AS, Ark N, Lin HY, Lee JJ, El-Naggar AK, Hong WK, Shin DM, Khuri FR. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol. 2009; 27:1976–1982.

21. Forastiere AA, Shaha AR. Chemoterapy alone for laryngeal preservation-is it possible. J Clin Oncol. 2009; 27:1933–1934.

22. Lefebvre JL, Lartigau E. Preservation of form and function during management of cancer of the larynx and hypopharynx. World J Surg. 2003; 27:811–816.

23. Radcliffe G, Shaw HJ. Partial laryngectomy for recurrent cancer after irradiation. Clin Otolaryngol. 1978; 3:49–62.

24. Stell PM, Dalby JE, Singh SD, Ramadan MF, Bainton R. The management of glottis T3 carcinoma. Clin Otolaryngol Allied Sci. 1982; 7:175–180.

25. Hill BT, Price LA. The potential role of chemotherapy in improving survival in some common cancers. Pharm Int. 1984; 5:268–272.

26. Kisch JA, Ensley JF, Weaver A. Improvement of complete response rate to induction chemotherapy for advanced squamous cell carcinoma of the head and neck. In : Jones SE, Salmon SE, editors. Adjuvant therapy of cancer IV. New York, USA: Grune & Stratton;1985. p. 107–111.

27. Jacob C, Wolf G, Mahuch R. Adjuvant chemotherapy for head and neck squamous carcinomas. Proc Am Soc Clin Oncol. 1984; 3:182.